Gemina Labs to Present at the Life Science Investor Forum June 20th
June 17, 2024 08:35 ET
|
Virtual Investor Conferences
VANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Gemina Laboratories Ltd (CSE:GLAB) based in Burnaby focused on diagnostic technologies for Point of Care Diagnostics today...
Triumph Financial and C.H. Robinson Announce Strategic Relationship
June 17, 2024 08:35 ET
|
Triumph Financial, Inc.
Triumph Financial and C.H. Robinson announced today a strategic relationship focused on delivering innovative payment solutions.
Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
June 17, 2024 08:32 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced...
Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension
June 17, 2024 08:32 ET
|
Aerovate Therapeutics, Inc.
WALTHAM, Mass., June 17, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE) today announced topline results from the Phase 2b portion of the Inhaled iMatinib Pulmonary Arterial...
P10 Announces Results of its Annual Meeting of Stockholders
June 17, 2024 08:30 ET
|
P10, Inc.
DALLAS, June 17, 2024 (GLOBE NEWSWIRE) -- P10, Inc. (NYSE: PX) (the “Company”), a leading private markets solutions provider, announced the voting results of its Annual Meeting of Stockholders. All...
Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy
June 17, 2024 08:30 ET
|
Mustang Bio, Inc.
Overall response rate of 90% in cohort with durable responses observed; one patient remains in complete remission at 31 months All patients were heavily pretreated/refractory to BTK inhibitors, and...
Orrstown Financial Services, Inc. and Codorus Valley Bancorp, Inc. Announce Receipt of Regulatory Approvals for Merger of Equals
June 17, 2024 08:30 ET
|
Orrstown Financial Services, Inc.; Codorus Valley Bancorp, Inc.
SHIPPENSBURG, Pa. and YORK, Pa., June 17, 2024 (GLOBE NEWSWIRE) -- Orrstown Financial Services, Inc. (“Orrstown”) (NASDAQ: ORRF), the parent company of Orrstown Bank, and Codorus Valley Bancorp,...
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
June 17, 2024 08:30 ET
|
Evoke Pharma, Inc.
Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024 Promoted former VP of Finance, Mark Kowieski to Chief Financial Officer SOLANA...
Atossa Set to Join Russell 3000® Index Effective June 28, 2024
June 17, 2024 08:30 ET
|
Atossa Therapeutics, Inc.
SEATTLE, June 17, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced its expected upcoming inclusion in the Russell 3000® Index, according...
Nature’s Sunshine Honored with Comparably Awards for Best Leadership Team and Best Career Growth
June 17, 2024 08:30 ET
|
Nature's Sunshine Products, Inc.
LEHI, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR), a leading natural health and wellness company offering high-quality herbal and nutritional...
- June 17, 2024 08:30 ET Nature’s Sunshine Honored with Comparably Awards for Best Leadership Team and Best Career Growth
- June 17, 2024 08:30 ET Water First Launches New Program Together with Six First Nations Communities in Ontario